|
1
|
Ou SH, Zell JA, Ziogas A and Anton-Culver
H: Epidemiology of nasopharyngeal carcinoma in the United States:
Improved survival of Chinese patients within the keratinizing
squamous cell carcinoma histology. Ann Oncol. 18:29–35. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee AW, Ma BB, Ng WT and Chan AT:
Management of nasopharyngeal carcinoma: Current practice and future
perspective. J Clin Oncol. 33:3356–3364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruce JP, Yip K, Bratman SV, Ito E and Liu
FF: Nasopharyngeal cancer: Molecular landscape. J Clin Oncol.
33:3346–3355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z, Tseng CP, Pong RC, Chen H,
McConnell JD, Navone N and Hsieh JT: The mechanism of
growth-inhibitory effect of DOC-2/DAB2 in prostate cancer.
Characterization of a novel GTPase-activating protein associated
with N-terminal domain of DOC-2/DAB2. J Biol Chem. 277:12622–12631.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu L, Xu C, Hsieh JT, Gong J and Xie D:
DAB2IP in cancer. Oncotarget. 7:3766–3776. 2016.PubMed/NCBI
|
|
6
|
Tsai YS, Lai CL, Lai CH, Chang KH, Wu K,
Tseng SF, Fazli L, Gleave M, Xiao G, Gandee L, et al: The role of
homeostatic regulation between tumor suppressor DAB2IP and
oncogenic Skp2 in prostate cancer growth. Oncotarget. 5:6425–6436.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen H, Toyooka S, Gazdar AF and Hsieh JT:
Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in
prostate cancer cell lines. J Biol Chem. 278:3121–3130. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen H, Tu SW and Hsieh JT:
Down-regulation of human DAB2IP gene expression mediated by
polycomb Ezh2 complex and histone deacetylase in prostate cancer. J
Biol Chem. 280:22437–22444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang J, Wang B, Hui K, Zeng J, Fan J,
Wang X, Hsieh JT, He D and Wu K: miR-92b targets DAB2IP to promote
EMT in bladder cancer migration and invasion. Oncol Rep.
36:1693–1701. 2016.PubMed/NCBI
|
|
10
|
Xu Y, He J, Wang Y, Zhu X, Pan Q, Xie Q
and Sun F: miR-889 promotes proliferation of esophageal squamous
cell carcinomas through DAB2IP. FEBS Lett. 589:1127–1135. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang B, Huang J, Zhou J, Hui K, Xu S, Fan
J, Li L, Wang X, Hsieh JT, He D, et al: DAB2IP regulates EMT and
metastasis of prostate cancer through targeting PROX1 transcription
and destabilizing HIF1α protein. Cell Signal. 28:1623–1630. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhou J, Ning Z, Wang B, Yun EJ, Zhang T,
Pong RC, Fazli L, Gleave M, Zeng J, Fan J, et al: DAB2IP loss
confers the resistance of prostate cancer to androgen deprivation
therapy through activating STAT3 and inhibiting apoptosis. Cell
Death Dis. 6:e19552015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou J, Luo J, Wu K, Yun EJ, Kapur P, Pong
RC, Du Y, Wang B, Authement C, Hernandez E, et al: Loss of DAB2IP
in RCC cells enhances their growth and resistance to mTOR-targeted
therapies. Oncogene. 35:4663–4674. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yeh CR, Ou ZY, Xiao GQ, Guancial E and Yeh
S: Infiltrating T cells promote renal cell carcinoma (RCC)
progression via altering the estrogen receptor β-DAB2IP signals.
Oncotarget. 6:44346–44359. 2015.PubMed/NCBI
|
|
15
|
Min J, Liu L, Li X, Jiang J, Wang J, Zhang
B, Cao D, Yu D, Tao D, Hu J, et al: Absence of DAB2IP promotes
cancer stem cell like signatures and indicates poor survival
outcome in colorectal cancer. Sci Rep. 5:165782015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Zhu X, Hu J, He G, Li X, Wu P, Ren
X, Wang F, Liao W, Liang L, et al: The positive feedback between
Snail and DAB2IP regulates EMT invasion and metastasis in
colorectal cancer. Oncotarget. 6:27427–27439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tu K, Yang W, Li C, Zheng X, Lu Z, Guo C,
Yao Y and Liu Q: Fbxw7 is an independent prognostic marker and
induces apoptosis and growth arrest by regulating YAP abundance in
hepatocellular carcinoma. Mol Cancer. 13:1102014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shao J, Yang X, Liu T, Zhang T, Xie QR and
Xia W: Autophagy induction by SIRT6 is involved in oxidative
stress-induced neuronal damage. Protein Cell. 7:281–290. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu M, Ye X, Deng X, Wu Y, Li X and Zhang
L: Upregulation of metastasis-associated gene 2 promotes cell
proliferation and invasion in nasopharyngeal carcinoma. Onco
Targets Ther. 9:1647–1656. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wong AM, Kong KL, Chen L, Liu M, Wong AM,
Zhu C, Tsang JW and Guan XY: Characterization of CACNA2D3 as a
putative tumor suppressor gene in the development and progression
of nasopharyngeal carcinoma. Int J Cancer. 133:2284–2295. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hazan I, Hofmann TG and Aqeilan RI: Tumor
suppressor genes within common fragile sites are active players in
the DNA damage response. PLoS Genet. 12:e10064362016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Paysan L, Piquet L, Saltel F and Moreau V:
Rnd3 in cancer: A review of the evidence for tumor promoter or
suppressor. Mol Cancer Res. 14:1033–1044. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao M, Luo R, Liu Y, Gao L, Fu Z, Fu Q,
Luo X, Chen Y, Deng X, Liang Z, et al: miR-3188 regulates
nasopharyngeal carcinoma proliferation and chemosensitivity through
a FOXO1-modulated positive feedback loop with
mTOR-p-PI3K/AKT-c-JUN. Nat Commun. 7:113092016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang CF, Yang GD, Huang TJ, Li R, Chu QQ,
Xu L, Wang MS, Cai MD, Zhong L, Wei HJ, et al: EB-virus latent
membrane protein 1 potentiates the stemness of nasopharyngeal
carcinoma via preferential activation of PI3K/AKT pathway by a
positive feedback loop. Oncogene. 35:3419–3431. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie D, Gore C, Zhou J, Pong RC, Zhang H,
Yu L, Vessella RL, Min W and Hsieh JT: DAB2IP coordinates both
PI3K-Akt and ASK1 pathways for cell survival and apoptosis. Proc
Natl Acad Sci USA. 106:19878–19883. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen YJ, Kong ZL, Wan FN, Wang HK, Bian
XJ, Gan HL, Wang CF and Ye DW: Downregulation of DAB2IP results in
cell proliferation and invasion and contributes to unfavorable
outcomes in bladder cancer. Cancer Sci. 105:704–712. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhuang YJ, Liao ZW, Yu HW, Song XL, Liu Y,
Shi XY, Lin XD and Zhou TC: ShRNA-mediated silencing of the
ubiquitin-specific protease 22 gene restrained cell progression and
affected the Akt pathway in nasopharyngeal carcinoma. Cancer Biol
Ther. 16:88–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Z, Liu D, Fan C, Luan L, Zhang X and
Wang E: DIXDC1 increases the invasion and migration ability of
non-small-cell lung cancer cells via the PI3K-AKT/AP-1 pathway. Mol
Carcinog. 53:917–925. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, et al:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yip WK, Leong VC, Abdullah MA, Yusoff S
and Seow HF: Overexpression of phospho-Akt correlates with
phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal
carcinoma. Oncol Rep. 19:319–328. 2008.PubMed/NCBI
|
|
31
|
Lai JP, Tong CL, Hong C, Xiao JY, Tao ZD,
Zhang Z, Tong WM and Betz CS: Association between high initial
tissue levels of cyclin d1 and recurrence of nasopharyngeal
carcinoma. Laryngoscope. 112:402–408. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen J, Kwong DL, Zhu CL, Chen LL, Dong
SS, Zhang LY, Tian J, Qi CB, Cao TT, Wong AM, et al: RBMS3 at 3p24
inhibits nasopharyngeal carcinoma development via inhibiting cell
proliferation, angiogenesis, and inducing apoptosis. PLoS One.
7:e446362012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma BB, Lui VW, Hui CW, Lau CP, Wong CH,
Hui EP, Ng MH, Tsao SW, Li Y and Chan AT: Preclinical evaluation of
the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines.
Invest New Drugs. 31:567–575. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu W, Xiao L, Cao C, Hua S and Wu D: UBE2T
promotes nasopharyngeal carcinoma cell proliferation, invasion, and
metastasis by activating the AKT/GSK3β/β-catenin pathway.
Oncotarget. 7:15161–15172. 2016.PubMed/NCBI
|
|
35
|
Bellazzo A, Di Minin G and Collavin L:
Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in
cancer. Cell Death Differ. 24:15–25. 2017. View Article : Google Scholar : PubMed/NCBI
|
